CTRI/2020/11/029206Not yet recruiting未知
Pharmacogenomics and Population Pharmacokinetic Integration for Precision Therapy of Tapentadol in Palliative Cancer Patients
Trial Snapshot
- Phase
- 未知
- Status
- Not yet recruiting
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
Inclusion Criteria
- •Patients of age >18 years and <70 years, from either sex.
- •Patients with moderate to severe pain {pain >4 measured on numerical rating scale (NRS)}.
- •Willing to participate in the study and provide written informed consent.
Exclusion Criteria
- •Pregnant/lactating women.
- •Patients already on MAO inhibitors, serotonin reuptake inhibitors, and Tricyclic antidepressants [contraindicated drugs].
Investigators
Similar Trials
Not yet recruiting
Unknown
Drug levels of Mycophenolic acid and the genetic mutations that affects these blood levels in patients with autoimmune diseases taking durg mycophenolate mofetil (MMF)CTRI/2023/03/050985Seth GS Medical College and KEM Hospital
Recruiting
Not Applicable
Study of factors (including genetic factors) influencing the levels of tacrolimus in blood before and after intake in renal transplant patientsCTRI/2013/08/003871Jawaharlal Institute of Post Graduate Medical Education and Research JIPMER30
Recruiting
Not Applicable
Genomic Study for Determination of Precise dose of Isoniazid in TB Patients.CTRI/2019/05/019105evin Thomas
Recruiting
Not Applicable
Population pharmacokinetic and pharmacodynamic modeling of propofol in underweight patients under general anesthesiaKCT0001760Asan Medical Center20
Active, not recruiting
Not Applicable
Population pharmacokinetic and pharmacodynamic modeling of gabapentin in neuropathic pain - Effect of adjuvant pharmacotherapyEUCTR2009-010783-41-SEppsala University